CareDx, Inc. (CDNA) 8-K Current Report: February 25, 2026
Filed: February 25, 2026
Health Care
Services-Medical LaboratoriesCareDx, Inc. (CDNA) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items3 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
- Item 2.02: Results of Operations and Financial Condition
CareDx, Inc. 8-K Feb 25, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 2025 earnings released Feb 24, 2026 — full results in Exhibit 99.1
- • Quarter ended Dec 31, 2025 covered; specific financials available in attached press release
Item 5.02 · Departure/Election of Directors or Officers
- • Keith Kennedy (age 56) elevated from COO to CFO+COO dual role, effective Feb 26, 2026 — adds financial oversight to existing operational responsibilities
- • Kennedy brings prior CFO experience at Veracyte and PharmaLogic; CFA + CPA credentials signal strong financial controls background
- • Outgoing CFO Nathan Smith resigned for personal reasons Feb 25, 2026 — explicitly not due to disagreement over financials or disclosures
- • Smith separation package: 9 months base salary (lump sum), $91,643 bonus, 9 months COBRA, and 5,840 RSUs vested pro rata
- • Dual CFO/COO role under one executive is a notable structural consolidation — investors should monitor whether this signals cost discipline or leadership depth concerns
Item 7.01 · Regulation FD Disclosure
- • Updated corporate presentation posted to website, current as of Feb 24, 2026
- • Reg FD disclosure ensures institutional and retail investors receive simultaneous access to material information
- • Company explicitly disclaims future update obligations — presentation may become stale quickly
Other CareDx, Inc. 8-K Filings
Get deeper insights on CareDx, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.